Anti-VEGF Anticancer Drugs: Mind the Hypertension

E-ISSN： 2212-3962|9|2|63-72

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.9, Iss.2, 2014-12, pp. : 63-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery

Current Diabetes Reviews, Vol. 7, Iss. 3, 2011-05 ,pp. : 176-184

Bentham Science Publishers

Access to resources Recommend Favorite

The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs

Current Vascular Pharmacology, Vol. 9, Iss. 3, 2011-05 ,pp. : 358-380

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension

Current Hypertension Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

By Wang Yaning

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

By Simó R.

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1574-1580

Springer Publishing Company

Access to resources Recommend Favorite